Ajinomoto Group Expands Cysteine Derivatives Production Capacity - Beckley, Bluefield & Lewisburg News, Weather, Sports

Ajinomoto Group Expands Cysteine Derivatives Production Capacity

Posted:

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE:

Ajinomoto Co. subsidiary to increase Cysteine derivatives production in 2014

Tokyo, Japan (PRWEB) July 15, 2014

Ajinomoto Co., Inc. (Ajinomoto Co.) has announced that its subsidiary Nippon Protein Co., Ltd. in Japan will increase Cysteine derivatives production capacity during 2014.

Cysteine derivatives are amino acids widely used in various applications such as pharmaceutical products, bread (dough conditioner), flavors and cosmetics. Many Cysteine derivatives from other manufacturers are produced through an extraction process using animal-origin material, such as human hair and bird feathers; however, Ajinomoto Co. has developed a production method by fermentation based on raw material from vegetable sources. Making use of our own technology for producing Cysteine derivatives, Ajinomoto Co. began supplying fermentation-origin products to the market last year.

The demand for fermentation-origin Cysteine derivatives is dramatically increasing as the demand for animal-source products has fallen. Human hair and bird feather extraction methods are losing favor, in part due to the heavy environmental burdens - such as the creation of large amounts of waste water - that result from the process. Accordingly, demand for our fermentation-origin Cysteine derivatives - which is considered sustainable - is surging globally. Ajinomoto Co. is expanding to accommodate this increased demand and will prepare for further expansion to cope with customers demand.

Ajinomoto will make the best effort to meet the market requirement by making use of our advantageous fermentation technology.

For the original version on PRWeb visit: http://www.prweb.com/releases/Ajinomoto-Expands-/Cysteine-Derivatives/prweb12012952.htm

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.